華爾街頂級分析師改變了對這些頂級公司的看法。有關所有分析師評級變動的完整視圖，包括上調、下調和首次評級，請查看我們的 分析師評級頁面。
<ul>
<li>Keybanc 分析師 Bradley B. Thomas 將 Purple Innovation Inc (NASDAQ: PRPL) 的評級從超配下調至行業配置。Purple Innovation 股價週二收於 $0.53。查看其他分析師對該股票的看法。</li>
<li>Barrington Research 分析師 Michael Petusky 將 OPKO Health Inc (NASDAQ: OPK) 的評級從跑贏大盤下調至市場表現。OPKO Health 股價週二收於 $1.21。查看其他分析師對該股票的看法。</li>
<li>JP Morgan 分析師 Drew Levine 將 Brown-Forman Corp(NYSE: BF.B) 的評級從中性下調至弱於大盤，並將目標價從 $27 下調至 $23。Brown-Forman 股價週二收於 $27.73。查看其他分析師對該股票的看法。</li>
<li>UBS 分析師 Kaio Prato 將 MercadoLibre Inc (NASDAQ: MELI) 的評級從買入下調至中性，並將目標價從 $2,700 下調至 $2,050。MercadoLibre 股價週二收於 $1,791.99。查看其他分析師對該股票的看法。</li>
<li>William Blair 分析師 Jonathan Ho 將 Rapid7, Inc. (NASDAQ: RPD) 的評級從跑贏大盤下調至市場表現。Rapid7 股價週二收於 $5.82。查看其他分析師對該股票的看法。</li>
</ul>
考慮購買 PRPL 股票嗎？以下是分析師的看法：
<img src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png"/>
圖片來源於 Shutterstock

PRPL

拉美商業服務

OPKO保健

BF.B

華爾街分析師已下調了幾隻股票的評級，包括將 Purple Innovation (PRPL) 從 “增持” 下調至 “行業權重”，將 OPKO Health (OPK) 從 “跑贏大盤” 下調至 “市場表現”，將 Brown-Forman (BF.B) 從 “中性” 下調至 “減持”，並將其目標價從 27 美元下調至 23 美元，將 MercadoLibre (MELI) 從 “買入” 下調至 “中性”，目標價從 2,700 美元下調至 2,050 美元，以及將 Rapid7 (RPD) 從 “跑贏大盤” 下調至 “市場表現”。分析師對這些變化提供了見解，反映出市場情緒的轉變

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
<div class="lb-trans">華爾街頂級分析師改變了對這些頂級公司的看法。有關所有分析師評級變動的完整視圖，包括上調、下調和首次評級，請查看我們的 分析師評級頁面。
</div><ul>
<li>Keybanc analyst Bradley B. Thomas downgraded Purple Innovation Inc (NASDAQ: PRPL) from Overweight to Sector Weight. Purple Innovation shares closed at $0.53 on Tuesday. See how other analysts view this stock.</li>
<li>Barrington Research analyst Michael Petusky downgraded OPKO Health Inc (NASDAQ: OPK) from Outperform to Market Perform. OPKO Health shares closed at $1.21 on Tuesday. See how other analysts view this stock.</li>
<li>JP Morgan analyst Drew Levine downgraded Brown-Forman Corp(NYSE: BF.B) from Neutral to Underweight and cut the price target from $27 to $23. Brown-Forman shares closed at $27.73 on Tuesday. See how other analysts view this stock.</li>
<li>UBS analyst Kaio Prato downgraded MercadoLibre Inc (NASDAQ: MELI) from Buy to Neutral and cut the price target from $2,700 to $2,050. MercadoLibre shares closed at $1,791.99 on Tuesday. See how other analysts view this stock.</li>
<li>William Blair analyst Jonathan Ho downgraded Rapid7, Inc. (NASDAQ: RPD) from Outperform to Market Perform. Rapid7 shares closed at $5.82 on Tuesday. See how other analysts view this stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>Keybanc 分析師 Bradley B. Thomas 將 Purple Innovation Inc (NASDAQ: PRPL) 的評級從超配下調至行業配置。Purple Innovation 股價週二收於 $0.53。查看其他分析師對該股票的看法。</li>
<li>Barrington Research 分析師 Michael Petusky 將 OPKO Health Inc (NASDAQ: OPK) 的評級從跑贏大盤下調至市場表現。OPKO Health 股價週二收於 $1.21。查看其他分析師對該股票的看法。</li>
<li>JP Morgan 分析師 Drew Levine 將 Brown-Forman Corp(NYSE: BF.B) 的評級從中性下調至弱於大盤，並將目標價從 $27 下調至 $23。Brown-Forman 股價週二收於 $27.73。查看其他分析師對該股票的看法。</li>
<li>UBS 分析師 Kaio Prato 將 MercadoLibre Inc (NASDAQ: MELI) 的評級從買入下調至中性，並將目標價從 $2,700 下調至 $2,050。MercadoLibre 股價週二收於 $1,791.99。查看其他分析師對該股票的看法。</li>
<li>William Blair 分析師 Jonathan Ho 將 Rapid7, Inc. (NASDAQ: RPD) 的評級從跑贏大盤下調至市場表現。Rapid7 股價週二收於 $5.82。查看其他分析師對該股票的看法。</li>
</ul>
</div>Considering buying PRPL stock? Here’s what analysts think:
<div class="lb-trans">考慮購買 PRPL 股票嗎？以下是分析師的看法：
</div><img src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png" alt="" original-src="https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png"/>
Photo via Shutterstock
<div class="lb-trans">圖片來源於 Shutterstock
</div>

這位 Purple Innovation 的分析師不再持樂觀態度；以下是週三的五大評級下調